• head_banner_01

Bottom price Vancomycin By Mouth - Impurities of Amino Acid Used for Synthesize Protein – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

No matter new customer or old customer, We believe in long term and trusted relationship for Chromium 3 Acetate, Lemborexant, 4-Bromophenylacetonitrile, We sincerely welcome both foreign and domestic business partners, and hope to work with you in the near future!
Bottom price Vancomycin By Mouth - Impurities of Amino Acid Used for Synthesize Protein – Gentolex Detail:

Product Detail

NO

Products

CAS No

Key Quality Indicator

Purity

Max.

impurity

Total solvent residue

Moisture

1

Fmoc-β-Ala-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

Fmoc-D-Ala-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

Fmoc-β-Ala-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

Fmoc-β-Ala-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

Fmoc-β-Ala-D-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

Fmoc-β-Ala-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

Fmoc-Asn(Trt)-Asn(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

Fmoc-β-Ala-Asn(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

Fmoc-Asp(OtBu)-Asp(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

Fmoc-β-Ala-Asp(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

Fmoc-Cys(Trt)-Cys(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

Fmoc-β-Ala-Cys(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

Fmoc-Cys(Acm)-Cys(Acm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

Fmoc-β-Ala-Cys(Acm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

Fmoc-Gln(Trt)-Gln(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

Fmoc-β-Ala-Gln(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

Fmoc-Glu(OtBu)-Glu(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

Fmoc-β-Ala-Glu(OtBu)-OH.H2O

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

Fmoc-β-Ala-Gly-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

Fmoc-His(Trt)-His(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

Fmoc-β-Ala-His(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

Fmoc-Ile-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

Fmoc-β-Ala-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

Fmoc-Leu-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

Fmoc-β-Ala-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

Fmoc-D-Leu-D-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

Fmoc-β-Ala-D-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

Fmoc-Lys(Boc)-Lys(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

Fmoc-β-Ala-Lys(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

Fmoc-Lys(Alloc)-Lys(Alloc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

Fmoc-β-Ala-Lys(Alloc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

Fmoc-Met-Met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

Fmoc-β-Ala-Met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

Fmoc-Orn(Boc)-Orn(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

Fmoc-β-Ala-Orn(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

Fmoc-Phe-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

Fmoc-β-Ala-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

Fmoc-D-Phe-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

Fmoc-β-Ala-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

Fmoc-Pro-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

Fmoc-β-Ala-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

Fmoc-Ser(tBu)-Ser(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

Fmoc-β-Ala-Ser(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

Fmoc-Ser(Trt)-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

Fmoc-β-Ala-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

Fmoc-Thr(tBu)-Thr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

Fmoc-β-Ala-Thr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

Fmoc-Trp(Boc)-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

Fmoc-β-Ala-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

Fmoc-β-Ala-D-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

Fmoc-Tyr(tBu)-Tyr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

Fmoc-β-Ala-Tyr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

Fmoc-β-Ala-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

Fmoc-Tyr(Me)-Tyr(Me)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

Fmoc-β-Ala-Tyr(Me)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

Fmoc-Val-Val-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

Fmoc-β-Ala-Val-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

Fmoc-D-Cit-D-Cit-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

Fmoc-β-Ala-D-Cit-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

Fmoc-β-Ala-Dab-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

Fmoc-(3-(2-naphthyl)-D-Ala)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

Fmoc-(4-chloro-D-Phe)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

Fmoc-β-Ala-4-chloro-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

Fmoc-(D-4Aph(tBuCbm))2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

Fmoc-β-Ala-D-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

Fmoc-β-Ala-Aph(L-Hor)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

Fmoc-β-Ala-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

Fmoc-β-Ala-AEEA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

Fmoc-Aib-Aib-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

Fmoc-β-Ala-Aib-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

Fmoc-Arg-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-Arg(pbf)-OH

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

Fmoc-D-Arg-OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

H-D-Arg(pbf)-OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

Fmoc-HomoArg-OH.HCl

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

Fmoc-D-HomoArg-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

H-D-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

Fmoc-Asn-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-Asn(Trt)-OH

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

Fmoc-Asp-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-Asp(OtBu)-OH

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

Fmoc-Cys-OH

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-Cys(Trt)-OH

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-Cys(Acm)-OH.HCl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

Fmoc-Gln-OH

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-Gln(Trt)-OH

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

Fmoc-Glu-OH

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-Glu(OtBu)-OH.H2O

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

Fmoc-His-OH

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-His(Trt)-OH

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-His-OH

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

Fmoc-Lys-OH

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-Lys(Boc)-OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-Lys(Alloc)-OH

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

Fmoc-Orn-OH.HCl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-Orn(Boc)-OH

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

Fmoc-Ser-OH

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-Ser(tBu)-OH

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

Fmoc-Thr-OH.H2O

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-Thr(tBu)-OH

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

Fmoc-Trp-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-Trp(Boc)-OH

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

Fmoc-D-Trp-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

H-D-Trp(Boc)-OH

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

Fmoc-Tyr-OH

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-Tyr(tBu)-OH

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

Fmoc-D-Tyr-OH

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

H-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-Tyr(Me)-OH.HCl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

Fmoc-D-4Aph(Cbm)-OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

H-D-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

Fmoc-Lys(iPr)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

About

Compensation

Gentolex provide great quality products, if any product quality is raised by the client within the required time frame with sufficient evidences, we will provide necessary analysis and evaluation to trigger the procedures of compensations.

Production

The capacities of pharmaceutical products reached tons grade, the capacities of chemical products reach 100tons+ grade, the capabilities are well equipped to serve clients worldwide.

Research and Development

Every year, there is plan set up by the R&D team to develop different new products, when targets set, every member in the team will have to carry on with KPI responsibility and with incentive policy.


Product detail pictures:

Bottom price Vancomycin By Mouth - Impurities of Amino Acid Used for Synthesize Protein – Gentolex detail pictures


Related Product Guide:

Reliable quality and good credit standing are our principles, which will help us at a top-ranking position. Adhering to the tenet of "quality first, customer supreme" for Bottom price Vancomycin By Mouth - Impurities of Amino Acid Used for Synthesize Protein – Gentolex , The product will supply to all over the world, such as: Barbados, Montpellier, Azerbaijan, Our team knows well the market demands in different countries, and is capable of supplying suitable quality products and solutions at the best prices to different markets. Our company has already set up a experienced, creative and responsible team to develop clients with the multi-win principle.
  • The product manager is a very hot and professional person, we have a pleasant conversation, and finally we reached a consensus agreement.
    5 Stars By Julia from Tajikistan - 2018.09.23 17:37
    The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
    5 Stars By Eden from Toronto - 2018.06.12 16:22
    Write your message here and send it to us